Friday 6 November 2026 Export ACAD’s income statement to Excel — free account

ACADIA Pharmaceuticals Inc.

ACADIA Pharmaceuticals Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.1 billion, up 11.9% from fiscal 2024.

Revenue: +22.9%
EPS: −27.9%
Free cash flow: +141.2%

Quarter to September 2026, against a year earlier

Revenue growth 10 yrs

21.23 0.01 −0.05%

Follow ACAD

Alert me

Market cap: $3.7B
P/E: 10.0×
Fwd P/E: 33.4×
Dividend yield: —
F-score: 6/9
Altman Z: 7.90
Beneish M: −0.89
Dividend safety: n/a

Overview

	Sep '26 From the 10-Q filed 5 Nov	Jun '26	Mar '26	Dec '25	Older periods
P/E ratio Full definition →	9.46	11.24	9.98	11.51	+8 more quarters Free account
P/S ratio Full definition →	2.89	3.81	3.47	4.20
P/FCF ratio Full definition →	0.00	0.00	0.00	0.00
P/Operating CF Full definition →	302.25	43.08	111.70	(92.28)
P/B ratio Full definition →	2.51	3.32	3.04	3.66
Price to Tangible BV Full definition →	2.78	3.61	3.32	4.02
EV/Sales Full definition →	2.08	2.97	2.69	3.43
EV/EBITDA Full definition →	26.02	35.22	33.10	33.08
EV/Operating CF Full definition →	25.64	21.12	23.84	33.48
EV/FCF Full definition →	(21.61)	(65.04)	(35.02)	(39.55)
Quick Ratio Full definition →	3.48	3.11	3.27	3.49
Current Ratio Full definition →	3.82	3.39	3.59	3.83
Net Debt/EBITDA Full definition →	0.00	(23.36)	410.14	(41.72)
Debt/Assets Full definition →	0.00%	0.00%	0.00%	0.00%
Debt/Equity Full definition →	0.00	0.00	0.00	0.00
Asset Turnover Full definition →	0.77	0.77	0.80	0.78
Operating CF/Net income Full definition →	0.21	3.20	9.34	(0.18)
Capex/Depreciation Full definition →	0.00	(1.64)	(2.05)	(1.78)
Research and Development Expense of Revenue Full definition →	22.29%	26.48%	28.68%	29.85%
Selling, General and Administrative Expense of Revenue Full definition →	46.51%	52.04%	63.80%	54.80%
Intangible Assets out of Total Assets Full definition →	0.08	0.06	0.07	0.07
Share Based Compensation of Revenue Full definition →	5.10%	5.50%	5.48%	4.66%
Graham Net Nets Full definition →	0.25	0.18	0.19	0.16
Graham Number Full definition →	19.63	19.63	19.16	19.51
Earnings Yield Full definition →	10.57%	8.89%	10.02%	8.69%
Free Cash Flow Yield Full definition →	(3.33%)	(1.20%)	(2.22%)	(2.07%)
Revenue per Share Full definition →	1.98	1.79	1.57	1.69
Operating CF per Share Full definition →	0.07	0.59	0.20	(0.29)
Capex per Share Full definition →	(0.01)	(0.03)	(0.03)	(0.02)
Free Cash Flow per Share Full definition →	0.06	0.56	0.17	(0.31)
Cash per Share Full definition →	5.66	5.57	4.99	4.87
Shareholders Equity per Share Full definition →	8.04	7.61	7.32	7.29
Interest Debt per Share Full definition →	0.00	0.00	0.00	0.00
Book value per Share Full definition →	8.04	7.61	7.32	7.29
Free Cash Flow Full definition →	10.26	95.69	28.77	(52.74)
Working Capital Full definition →	936.21	863.11	790.49	785.00
Capital Expenditures Full definition →	(1.24)	(5.09)	(5.21)	(4.00)
Net Current Asset Value Full definition →	861.76	788.25	738.85	725.31
EV/EBIT Full definition →	20.44	39.20	36.39	35.08
Capex to Sales Full definition →	0.00	0.02	0.02	0.01
Price to Operating Income Full definition →	28.42	50.27	46.92	42.90
Other line items
Average Receivables Full definition →	158.88	143.01	131.05	126.46
Average Payables Full definition →	19.04	32.33	15.17	13.55
Average Inventory Full definition →	34.73	29.25	27.26	28.31
Average Assets Full definition →	1,562.46	1,484.23	1,368.80	1,375.98
Average Common Equity Full definition →	1,152.38	1,064.50	1,006.65	980.09

Show all line items

Columns are period end dates · fundamentals updated 5 Nov 2026

Stockrow Weekly